Literature DB >> 28075491

Integrated classification of inflammatory myopathies.

Y Allenbach1,2, O Benveniste1,2, H-H Goebel3, W Stenzel3.   

Abstract

Inflammatory myopathies comprise a multitude of diverse diseases, most often occurring in complex clinical settings. To ensure accurate diagnosis, multidisciplinary expertise is required. Here, we propose a comprehensive myositis classification that incorporates clinical, morphological and molecular data as well as autoantibody profile. This review focuses on recent advances in myositis research, in particular, the correlation between autoantibodies and morphological or clinical phenotypes that can be used as the basis for an 'integrated' classification system.
© 2017 British Neuropathological Society.

Entities:  

Keywords:  Morphology; Myositis; autoantibodies; classification of IIMs

Mesh:

Year:  2017        PMID: 28075491     DOI: 10.1111/nan.12380

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  20 in total

Review 1.  Classification of myositis.

Authors:  Ingrid E Lundberg; Marianne de Visser; Victoria P Werth
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

2.  Immune myopathy with large histiocyte-related myofiber necrosis.

Authors:  Alan Pestronk; Namita Sinha; Ziad Alhumayyd; Cindy Ly; Robert Schmidt; Robert Bucelli
Journal:  Neurology       Date:  2019-03-20       Impact factor: 9.910

3.  Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of 'scleromyositis'.

Authors:  Benjamin Ellezam; Valérie Leclair; Yves Troyanov; Alain Meyer; Marie Hudson; Océane Landon-Cardinal
Journal:  Acta Neuropathol       Date:  2021-06-11       Impact factor: 17.088

Review 4.  Differentiating between UCTD and early-stage SLE: from definitions to clinical approach.

Authors:  Savino Sciascia; Dario Roccatello; Massimo Radin; Ioannis Parodis; Jinoos Yazdany; Guillermo Pons-Estel; Marta Mosca
Journal:  Nat Rev Rheumatol       Date:  2021-11-11       Impact factor: 20.543

5.  Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis.

Authors:  Corinna Preuße; Barbara Paesler; Christopher Nelke; Derya Cengiz; Thomas Müntefering; Andreas Roos; Damien Amelin; Yves Allenbach; Akinori Uruha; Carsten Dittmayer; Andreas Hentschel; Marc Pawlitzki; Sarah Hoffmann; Sara Timm; Sarah Leonard Louis; Nora F Dengler; Heinz Wiendl; Jan D Lünemann; Albert Sickmann; Baptiste Hervier; Sven G Meuth; Udo Schneider; Anne Schänzer; Sabine Krause; Stylianos Tomaras; Eugen Feist; Rebecca Hasseli; Hans-Hilmar Goebel; Laure Gallay; Nathalie Streichenberger; Olivier Benveniste; Werner Stenzel; Tobias Ruck
Journal:  Acta Neuropathol       Date:  2022-05-25       Impact factor: 15.887

Review 6.  Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2018-07-23       Impact factor: 3.598

7.  Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy.

Authors:  Ying Hou; Kai Shao; Yaping Yan; Tingjun Dai; Wei Li; Yuying Zhao; Duoling Li; Jian-Qiang Lu; Gary L Norman; Chuanzhu Yan
Journal:  J Neurol       Date:  2021-05-21       Impact factor: 4.849

Review 8.  Idiopathic inflammatory myopathies overlapping with systemic diseases.

Authors:  Sébastien Lepreux; Johannes A Hainfellner; Anne Vital
Journal:  Clin Neuropathol       Date:  2018 Jan/Feb       Impact factor: 1.368

Review 9.  Current Classification and Management of Inflammatory Myopathies.

Authors:  Jens Schmidt
Journal:  J Neuromuscul Dis       Date:  2018

10.  Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results.

Authors:  Fergus To; Clara Ventín-Rodríguez; Shuayb Elkhalifa; James B Lilleker; Hector Chinoy
Journal:  BMC Rheumatol       Date:  2020-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.